Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other large pharmaceutical companies, giving them until late September to cut the U.S. prices of certain drugs or the administration will “deploy every tool in our arsenal to protect American families.”

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy called "most favored nation."